InjectTab™ is an oral drug delivery system for biologics and large molecules. A revolutionary micro-needle capsule that confirms self-orientation and ideal positioning to deliver biologics via injection into the stomach wall.
TargetTab™ is an oral drug delivery system that can determine the capsule’s location in the gastrointestinal tract and trigger the release of drug therapy at a predetermined location for IBD and other GI related diseases.
SmartTab® recently published “Advancing High Tech Drug Delivery Systems for the Treatment of Crohn’s Disease” in Inflammatory Bowel Diseases (IBD) Journal, and the Journal of Gastroenterology. A poster of distinction, as one of the top-scoring abstracts at the Crohn's and Colitis Congress 2021.
December 12, 2020
25+ years of experience in the medical device; multi-national corporate R&D; 20+ years experience in active implantable devices; 5+ years in in-vitro diagnostics and pharmaceuticals; Led R&D, manufacturing, quality, and regulatory functions at VP level; 9 patents in the biomedical field; Published author; BS in Electrical Engineering; MS & PhD in Electrical/Biomedical Engineering.